Northwest & Ethical Investments’s Dr. Reddy's Laboratories RDY Stock Holding History

Northwest & Ethical Investments’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.22M	Buy	222,380 +160,688	+260%	+$2.17M	0.08%	170
2026 Q1	$854K	Buy	+61,692	New	+$859K	0.02%	325
2017 Q1	–	Sell	-84,630	Closed	-$766K	–	400
2016 Q4	$766K	Buy	84,630 +19,690	+30%	+$183K	0.05%	289
2016 Q3	$603K	Hold	64,940	–	–	0.04%	275
2016 Q2	$665K	Hold	64,940	–	–	0.05%	182
2016 Q1	$587K	Buy	64,940 +35,035	+117%	+$313K	0.04%	178
2015 Q4	$277K	Sell	29,905 -41,265	-58%	-$452K	0.02%	192
2015 Q3	$910K	Buy	71,170 +34,405	+94%	+$427K	0.07%	167
2015 Q2	$407K	Hold	36,765	–	–	0.03%	203
2015 Q1	$420K	Hold	36,765	–	–	0.03%	195
2014 Q4	$371K	Buy	36,765 +5,480	+18%	+$57.7K	0.03%	202
2014 Q3	$329K	Sell	31,285 -9,165	-23%	-$86.2K	0.02%	200
2014 Q2	$349K	Buy	40,450 +980	+2%	+$8.24K	0.02%	203
2014 Q1	$347K	Buy	39,470 +19,970	+102%	+$174K	0.02%	213
2013 Q4	$160K	Buy	+19,500	New	+$154K	0.01%	225

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Northwest & Ethical Investments's RDY Position: Q2 2026 in Review

Northwest & Ethical Investments increased its Dr. Reddy's Laboratories (RDY) stake by 260% in Q2 2026, buying an estimated $2.17M and bringing the position to 222,380 shares worth $3.22M. The position accounts for 0.08% of the portfolio, ranked #170.

Northwest & Ethical Investments first reported a position in RDY in Q4 2013 and has held it in 15 quarters since. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

Northwest & Ethical Investments held 222,380 shares of Dr. Reddy's Laboratories worth $3.22M as of Q2 2026.
Northwest & Ethical Investments bought 160,688 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $2.17M.
Dr. Reddy's Laboratories made up 0.08% of Northwest & Ethical Investments's portfolio in Q2 2026, its #170 holding.
Northwest & Ethical Investments first reported a position in Dr. Reddy's Laboratories in Q4 2013 and has held it in 15 quarters since.
238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Northwest & Ethical Investments's 13F filing for Q2 2026, filed 13 Aug 2026.